Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease

European Journal of Haematology

Volumn 59, Issue 2, 1997, Pages 115-120

  Blann, Andrew D ^a   Amiral, Jean ^b   McCollum, Charles N ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b PAE Parispace 3   (France)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Ischaemic heart disease; Soluble E selectin; Soluble thrombomodulin

Indexed keywords

CELL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030848264     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00735.x     Document Type: Article

References (27)

1. FUSTER V, BADIMON L, COHEN M, AMBROSE JA, BADIMON JJ, CHESEBRO JH. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988: 77: 1213-1220.
2. ROSS R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993: 362: 801-809.
3. MERA S. Atherosclerosis and coronary heart disease. Br J Biomed Sci 1993: 50: 235-248.
4. BLANN AD, AMIRAL J, MCCOLLUM CN. Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol 1996: 95: 263-265.
5. HAINES AP, HOWARTH D, NORTH WRS, et al. Haemostatic variables and the outcome of myocardial infarction. Thromb Haemostas 1983: 50: 800-803.
6. THOMPSON SG, KIENAST J, PYKE SDM, HAVERKATE F, VAN DE LOO JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995: 332: 635-641.
7. JANSSON JH, NILSSON TK, JOHNSON O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991: 66: 351-355.
8. MEADE TW, COOPER JA, STIRLING Y, HOWARTH DJ, RUDDOCK V, MILLER GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994: 88: 601-607.
9. CORTELLARO M, BOSCHETTI C, COFRANCESCO E, et al. The PLAT study: hemostatic factors in relation to atherothrombotic ischaemic events in vascular disease patients. Arterioscl Thromb 1992: 12: 1063-1069.
10. VIOLI F, CRIQUI M, LONGONI A, CASTIGLIONI T, FOR THE ADEP GROUP. Relationship between risk factors and cardiovascular disease in patients with peripheral vascular disease. Results from the ADEP study. Atherosclerosis 1996: 120: 25-32.
11. BERNHARD R, CORDAY E, ELIASCH H, et al. Nomenclature and criteria for diagnosis of ischaemic heart disease. Circulation 1979: 59: 607-609.
12. ROSE GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962: 27: 645-658.
13. Cox DR. Regression models and life tables (with discussion). J Roy Stat Soc 1972: 34: 187-220.
14. BAINTON D, SWEETHAM P, BAKER I, ELWOOD P Peripheral vascular disease: consequences for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 1994: 72: 218-224.
15. GEARING AJH, NEWMAN W. Circulating adhesion molecules in disease. Immunol Today 1993: 14: 506-512.
16. STEINER M, REINHARDT KM, KRAMMER B, ERNST B, BLANN AD. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemostas 1994: 72: 979-984.
17. PIGOTT R, DILLON LP, HEMINGWAY IH, GEARING AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Comm 1992: 187: 584-589.
18. BLANN AD, WAITE MA. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Coron Artery Dis 1996: 7: 143-147.
19. SEIGNEUR M, DUFOURCO P, CONRI C, et al. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993: 71: 425-431.
20. ESMON CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989: 264: 4743-4749.
21. ISHII H, MAJERUS PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985: 76: 2178-2184.
22. BLANN AD, TABERNER DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995: 90: 244-248.
23. POTTINGER BE, READ RC, PALEOLOG EM, HIGGINS PG, PEARSON JD. von Willebrand factor is an acute phase reactant in man. Thromb Res 1989: 53: 387-394.
24. HIROKAWA K, AOKI N. Up regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. J Biochem 1990: 108: 839-845.
25. BOFFA MC. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker. Haemostasis 1996: 26(Suppl 4): 233-243.
26. BLANN AD, DALY RJ, AMIRAL J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996: 92: 498-500.
27. CACOUB P, KARMOCHKINE M, DOREN R, et al. Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med 1996, 101: 160-164.